Avigan

Tablets of Avigan are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo. REUTERS/Issei Kato
Coronavirus chronicle

Fujifilm starts new late-phase trial of Avigan in Japan for Covid-19 patients

Fujifilm to restart clinical trial of Avigan to treat Covid-19: Media
Coronavirus chronicle

Fujifilm to restart clinical trial of Avigan to treat Covid-19: Media

FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato/File Photo
Coronavirus chronicle

India's Dr Reddy's ends study of Covid-19 drug Avigan in Kuwait

FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato/File Photo
Coronavirus chronicle

Fujifilm seeks approval for Avigan as Covid-19 treatment in Japan

FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato
Coronavirus chronicle

Fujifilm's Avigan shown to be effective in Japanese Phase-3 trial for Covid-19